Although ACTOS is still being sold in the US, two leading European countries stopped sales of the drug. A June 2011 European clinical study by the French National Health Insurance plan found a statistically significant risk of bladder cancer among 1.5 million diabetic patients taking Actos, with the risk increasing for periods of treatment longer than one year. A study by the French Medicines Agency found a 22 percent higher risk of bladder cancer in approximately 155,000 patients taking Actos from 2006 to 2009, compared to 1.3 million patients not taking the drug. The French Agency for the Safety of Health Products ordered an Actos recall in June 2011 in response. The German Federal Institute for Drugs and Medical Devices followed shortly thereafter by advising physicians not to prescribe Actos to diabetic patients.
Actos Has Been Linked To Increased Risk of Developing Bladder Cancer
The Brandi Law Firm is a leader in nationwide pharmaceutical litigation for decades and is now representing clients who have suffered bladder cancer related to Actos use and filed suits on their behalf. If you or a loved one has been diagnosed with bladder cancer and took the diabetes drug Actos, you may have a claim for your injuries. Please click here to speak to a Brandi Law Firm Actos Attorney for a no-cost consultation or call us at 1-800-481-1615 or contact us online.